Neuropathia diabetica–az oki kezelés patogenetikai alapjai [Diabetic neuropathy–pathogenetic background of the causal therapy]
G Winkler, P Kempler - Diabetologia Hungarica, 2021 - real.mtak.hu
Ma már általánosan elfogadott, hogy a diabeteses neuropathia gyógyításának meghatározó
tényezője a patogenetikai alapon nyugvó oki kezelés, amelyet a változó erősségű és …
tényezője a patogenetikai alapon nyugvó oki kezelés, amelyet a változó erősségű és …
[PDF][PDF] The potential role of benfotiamine in the treatment of diabetic cardiac autonomic neuropathy.
VA Serhiyenko, VB Segin… - International …, 2020 - iej.zaslavsky.com.ua
Background. Cardiac autonomic neuropathy is a serious complication of diabetes mellitus
that is strongly associated with approximately five-fold increased risk of cardiovascular …
that is strongly associated with approximately five-fold increased risk of cardiovascular …
[HTML][HTML] Effects of benfotiamine on the insulin resistance state, some pro-and anti-inflammatory factors content in patients with type 2 diabetes mellitus and cardiac …
VA Serhiyenko, AA Serhiyenko… - Russian Journal of …, 2018 - russjcardiol.elpub.ru
Aim. The aim of the study was to analyze the effect of benfotiamine (BFT) on the insulin
resistance state, the content of some pro-and anti-inflammatory factors in patients with type 2 …
resistance state, the content of some pro-and anti-inflammatory factors in patients with type 2 …
[图书][B] Modern Medicine and Pharmacology, Innovations and Perspectives
VOS Mohammed, R Nesterovska, V Serhiyenko… - 2021 - books.google.com
Text Copyright© 2021 by the Іnternational Science Group (isg-konf. com) and authors.
Illustrations© 2021 by the Іnternational Science Group and authors. Cover design …
Illustrations© 2021 by the Іnternational Science Group and authors. Cover design …
DIABETIC CARDIAC AUTONOMIC NEUROPATHY: EFFECT OF BENFOTIAMINE ON THE CORRECTED QT INTERVAL, QT DISPERSION AND SPATIAL QRS-T …
V Serhiyenko, M Hotsko… - Scientific Collection …, 2022 - archive.interconf.center
The significance of cardiac autonomic neuropathy (CAN) has not been fully appreciated and
there is no unified treatment algorithm. Aim: To investigate the effects of benfotiamine (BFT) …
there is no unified treatment algorithm. Aim: To investigate the effects of benfotiamine (BFT) …
Влияние бенфотиамина на состояние инсулиновой резистентности, содержание некоторых прои противоспалительных факторов при сахарном диабете и …
ВА Сергиенко, АА Сергиенко… - Российский …, 2018 - russjcardiol.elpub.ru
Аннотация Цель. Проанализировать влияние бенфотиамина (БФТ) на состояние
инсулиновой резистентности, содержание некоторых про-и противовоспалительных …
инсулиновой резистентности, содержание некоторых про-и противовоспалительных …
Effects of benfotiamine on the insulin resistance state, some proand anti-inflammatory factors content in patients with type 2 diabetes mellitus and cardiac autonomic …
VA Sergienko, AA Sergienko, VB Segin… - Российский …, 2019 - cyberleninka.ru
Aim. The aim of the study was to analyze the effect of benfotiamine (BFT) on the insulin
resistance state, the content of some proand anti-inflammatory factors in patients with type 2 …
resistance state, the content of some proand anti-inflammatory factors in patients with type 2 …
Потенциальная роль бенфотиамина в лечении диабетической автономной нейропатии сердца
ВА Сергиенко, ВБ Сегин, ЛМ Сергиенко… - Международный …, 2020 - cyberleninka.ru
Актуальность. Диабетическая нейропатия сердца серьезное осложнение сахарного
диабета, связанное с примерно пятикратным повышением риска сердечно-сосудистой …
диабета, связанное с примерно пятикратным повышением риска сердечно-сосудистой …
Benfotiamin a diabeteses neuropathia kezelésében [Benfotiamine in the therapy of diabetic neuropathy]
G Winkler, K Keresztes, G Jermendy… - DIABETOLOGIA …, 2021 - real.mtak.hu
Napjainkban a benfotiamin a neuropathiás károsodások oki kezelésének egyik
alapgyógyszere. Bár mind hatásmechanizmusa, mind klinikai alkalmazási lehetőségei jól …
alapgyógyszere. Bár mind hatásmechanizmusa, mind klinikai alkalmazási lehetőségei jól …
[PDF][PDF] Działanie benfotiaminy w farmakoterapii powikłań cukrzycy Benfotiamine effects in pharmacotherapy of diabetic complications
M Majewska, P Kozanecka, E Szałek - akademiamedycyny.pl
Vascular complications, microangiopathies such as neuropathy, nephropathy, retinopathy,
related to diabetes, rising due to chronic hyperglycaemia are one of the biggest challenges …
related to diabetes, rising due to chronic hyperglycaemia are one of the biggest challenges …